Literatura académica sobre el tema "Glioma patients"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Glioma patients".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Artículos de revistas sobre el tema "Glioma patients"
Jiang, Chongming, Evelien Schaafsma, Yanding Zhao, Thinh Nguyen, Kenneth Zhu y Chao Cheng. "Abstract LB528: A microglia associated gene signature predicts survival risk in glioma patients". Cancer Research 82, n.º 12_Supplement (15 de junio de 2022): LB528. http://dx.doi.org/10.1158/1538-7445.am2022-lb528.
Texto completoZhao, Shiguang. "BIOM-63. DIAGNOSIS AND PROGNOSTIC SIGNIFICANCE OF CIRCULATING miR-2276-5p IN PLASMA OF GLIOMA PATIENTS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii15. http://dx.doi.org/10.1093/neuonc/noaa215.060.
Texto completoLi, shaoqun, Mingyao Lai, Jiangfen Zhou, junjie Zhen y Linbo Cai. "PATH-22. GENETIC VARIATION BETWEEN IDH MUTANT AND IDH WILD-TYPE GLIOMA". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi119. http://dx.doi.org/10.1093/neuonc/noab196.474.
Texto completoPriambada, Dody, Muhamad Thohar Arifin, Surya Pratama Briliantika, Dian Widyaningrum, Abdi Saputro, Azka Tajussyarof El Muzakka, Yuriz Bakhtiar, Krisna Tsaniadi Prihastomo y Zainal Muttaqin. "Serum GFAP and EGFR as Supportive Diagnostic Biomarker of Glioma Patients: A Single-Center Study". Open Access Macedonian Journal of Medical Sciences 10, B (20 de abril de 2022): 1093–96. http://dx.doi.org/10.3889/oamjms.2022.9021.
Texto completoKim, Junhyung, Min Woo Park, Young Joon Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Jinhyung Heo et al. "miR-542-3p Contributes to the HK2-Mediated High Glycolytic Phenotype in Human Glioma Cells". Genes 12, n.º 5 (23 de abril de 2021): 633. http://dx.doi.org/10.3390/genes12050633.
Texto completoKim, Junhyung, Min Woo Park, Ju Won Ahn, Jeong Min Sim, Suwan Kim, Young Joon Park, Jinhyung Heo et al. "TAMI-47. MIR-542-3P CONTRIBUTES TO THE HK2-MEDIATED HIGH GLYCOLYTIC PHENOTYPE IN HUMAN GLIOMA CELLS". Neuro-Oncology 23, Supplement_6 (2 de noviembre de 2021): vi208. http://dx.doi.org/10.1093/neuonc/noab196.830.
Texto completoTran Anh Duc, Nguyen Thanh Bac, Nguyen Van Ba y Nguyen Duc Lien. "Study on some clinical features, histopathology and mutations in IDH, P53 genes, mgmt methylation in patients with high-grade glioma". VietNam Military Medical Unisversity 47, n.º 6 (8 de septiembre de 2022): 191–99. http://dx.doi.org/10.56535/jmpm.v47i6.66.
Texto completoVattemi, Emanuela, Giovanna Cipollini, Cristina Dealis, Lorena Rossi, Susanne Baier, Elisabetta Cretella, Giovanni Di Meglio et al. "Genetic polymorphisms of EGF 5'-UTR in patients with glioma: A possible predictive marker of outcome." Journal of Clinical Oncology 31, n.º 15_suppl (20 de mayo de 2013): e13009-e13009. http://dx.doi.org/10.1200/jco.2013.31.15_suppl.e13009.
Texto completoBracci, Paige, Terri Rice, Helen Hansen, Stephen Francis, Sean Lee, Lucie McCoy, Pavan Shrestha et al. "EPID-08. PRE-SURGERY IMMUNE PROFILES OF ADULT GLIOMA PATIENTS". Neuro-Oncology 22, Supplement_2 (noviembre de 2020): ii79—ii80. http://dx.doi.org/10.1093/neuonc/noaa215.326.
Texto completoLi, D., Y. Chen, C. Guo, Q. Yang, S. Wu, Y. Xia, J. Zeng et al. "P03.09 Real world management and prognosis of glioma patients:SYSUCC report from China". Neuro-Oncology 21, Supplement_3 (agosto de 2019): iii26—iii27. http://dx.doi.org/10.1093/neuonc/noz126.090.
Texto completoTesis sobre el tema "Glioma patients"
Lilja, Åsa. "Psychoneurooncology psychological dynamics in glioma patients /". Lund : Dept. of Psychology, Lund University, 1992. http://books.google.com/books?id=SnZrAAAAMAAJ.
Texto completoLombardi, Giuseppe. "2-Hydroxyglutarate as a biomarker in glioma patients". Doctoral thesis, Università degli studi di Padova, 2014. http://hdl.handle.net/11577/3423791.
Texto completoBackground: la mutazione del gene IDH1 rappresenta un importante fattore prognostico e diagnostico per i tumori gliali. L’enzima IDH1 avente la mutazione ha la capacità di convertire α-KG in 2-Idrossiglutarato (2HG) e i gliomi mutati hanno una elevata concentrazione di 2HG all’interno delle cellule tumorali. Poichè 2HG è una piccola molecola, tale metabolita potrebbe raggiungere la circolazione sistemica ed essere escreta con le urine. Per tale ragione, nel nostro studio abbiamo analizzato la concentrazione di 2HG nel plasma e nelle urine nei pazienti con glioma per identificare un biomarcatore surrogato della presenza della mutazione IDH1. Materiali e Metodi: per l’arruolamento, tutti i pazienti dovevano avere avuto una precedente conferma istologica di glioma, una recente risonanza magnetica cerebrale (entro 2 settimane) mostrante la lesione tumorale. Qualsiasi chemioterapia eseguita nei 28 giorni precedenti l’analisi del metabolita, la presenza di altre malattie tumorali e malattie metaboliche escludevano l’arruolamento del paziente. Campioni plasmatici e urinari sono stati ottenuti da tutti i pazienti e le concentrazioni di 2HG ottenute mediante cromatografia liquida-spettrometria di massa; il test di Mann-Whitney è stato usato per calcolare le differenze di concentrazione dei metaboliti tra pazienti con IDH1 mutato e non-mutato, per dati non parametrici; il test di Student per comparare dati parametrici. La curva ROC è stata usata per calcolare il valore di cut-off del 2HG come biomarcatore. Risultati: sono stati arruolati 84 pazienti: 38 con IDH1 mutato e 46 con IDH1 wildtype. Tutte le mutazioni sono state R132H. Tra i pazienti con mutazione IDH1 abbiamo avuto 21 gliomi ad alto grado (HGG) e 17 gliomi a basso grado (LGG). Tra i pazienti con IDH1 wild-type abbiamo avuto 35 pazienti con HGG e 11 con LGG. In tutti i pazienti abbiamo analizzato la concentrazione media di 2HG nel plasma (P_2HG), nell’urina (U_2HG) e il rapporto tra la concentrazione plasmatica e urinaria (R_2HG). E’ emersa una importante differenza statisticamente significativa per l’R_2HG tra pazienti con e senza mutazione dell’IDH1 (22.2 verso 15.6, p<0.0001). Il cut-off ottimale di R_2HG per identificare lo stato mutazionale di IDH1 nei pazienti con glioma è risultato essere 19 (sensibilità 63%, specificità 76%, accuratezza 70%); nei soli pazienti con glioma ad alto grado il cut-off ottimale è risultato essere 20 (sensibilità 76%, specificità 89%, accuratezza 84%, valore predittivo positivo 80%, valore predittivo negativo 86%). Non è emersa nessuna associazione tra il grado o la dimensione del tumore con il valore di R_2HG. In 7 pazienti con glioma ad alto grado analizzati abbiamo, inoltre, trovato una correlazione tra il valore di R_2HG e la risposta al trattamento. Conclusioni: attraverso l’analisi di R_2HG, derivato dalla concentrazione plasmatica e urinaria di 2HG, è possibile discriminare gliomi con e senza mutazione IDH1, soprattutto in gliomi di alto grado. Occorrerà analizzare un campione più grande di pazienti con glioma per investigare tale metodica anche nel follow up allo scopo di individuare precocemente la recidiva di malattia e per monitorare l’efficacia del trattamento.
Dan, Michael. "Human anti-glioma monoclonal antibodies from patients with neurological tumors". Thesis, McGill University, 1989. http://digitool.Library.McGill.CA:80/R/?func=dbin-jump-full&object_id=74367.
Texto completoGittleman, Haley Rebecca. "Nomograms and Sex Differences in Survival for Patients with Glioma". Case Western Reserve University School of Graduate Studies / OhioLINK, 2019. http://rave.ohiolink.edu/etdc/view?acc_num=case1562341173580061.
Texto completovan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery". Doctoral thesis, Università degli studi di Trento, 2018. https://hdl.handle.net/11572/367937.
Texto completovan, Ierschot Fleur Céline. "Monitoring of reading and spelling in glioma patients undergoing awake surgery". Doctoral thesis, University of Trento, 2018. http://eprints-phd.biblio.unitn.it/2834/1/FvI_PhD_thesis.pdf.
Texto completoDavies, Elizabeth. "The quality of survival of patients with malignant cerebal glioma following radiotherapy". Thesis, Queen Mary, University of London, 1998. http://qmro.qmul.ac.uk/xmlui/handle/123456789/1664.
Texto completoChikada, Ai. "A descriptive analysis of end-of-life discussions for high-grade glioma patients". Doctoral thesis, Kyoto University, 2021. http://hdl.handle.net/2433/264666.
Texto completo新制・課程博士
博士(人間健康科学)
甲第23385号
人健博第92号
新制||人健||6(附属図書館)
京都大学大学院医学研究科人間健康科学系専攻
(主査)教授 田村 恵子, 教授 稲富 宏之, 教授 溝脇 尚志
学位規則第4条第1項該当
Doctor of Human Health Sciences
Kyoto University
DFAM
Cavers, Debbie Grant. "Understanding the supportive care needs of glioma patients and their relatives : a qualitative longitudinal study". Thesis, University of Edinburgh, 2010. http://hdl.handle.net/1842/10630.
Texto completoCoget, Arthur. "Etude et modélisation de la plasticité cérébrale chez des patients porteurs de lésions gliales de bas grade opérés en chirurgie éveillée". Thesis, Montpellier, 2020. http://www.theses.fr/2020MONTS053.
Texto completoIntroductionDiffuse low-grade gliomas (DLGG) are slow-growing brain tumors occurring in young adults. This slow progression induces extensive neuroplasticity and explains why patients most of the time do not show any obvious neurological deficit at the time of diagnosis although tumors are located in ‘eloquent’ areas. Therefore DLGG provide an interesting model in understanding mechanisms of neuroplasticity.Awake surgery with direct cortical and subcortical electrostimulation mapping is recommended as first-line treatment of DLGG, allowing to maximize tumoral resection and limiting postoperative neurological deficit, maintaining patients quality of life.Resting-state fMRI, based on BOLD signal analysis, is used to study functional connectivity and neural plasticity. This technique allows robust evaluation of neural networks without performing a task. Consequently, it bypasses the impact of confusion, sedation or neurological deficits on task execution. In this thesis, we aimed to investigate perioperative functional connectivity modifications in order to evaluate neural plasticity after awake surgery.Subsequently we explained the functional results using multimodal MRI imaging to analyze anatomic connectivity and hemodynamic parameters.Methods82 patients with DLGG who underwent awake surgical resection were included in the principal study. MRI acquisitions were performed successively before, within 36 h after and three months post-surgery. All scans were executed on the same MRI magnet for each patient, i.e. either a 3.0 T magnet (Skyra, Siemens) or a 1.5 T magnet (Avanto, Siemens). First, data were preprossed using a standardized classical pipeline and analyzed with the CONN toolbox v16.a.Second, anatomic connectivity was evaluated using diffusion tensor imaging of the corpus callosum.Finally hemodynamic changes induced by surgery were assessed with traditional perfusion imaging as well as using an innovative analysis of the BOLD signal’ s temporal shift.ResultsSurprisingly, it was found that specifically a diffuse transient postoperative interhemispheric disconnectivity occurred between homologous regions, known as homotopic connectivity.In parallel, immediate and long-term postoperative alterations in the anatomic connectivity of the corpus callosum were observed. Immediate and long-term postoperative modifications were also found regarding both regional and global hemodynamics characteristics. Yet, no significant link between the homotopic connectivity findings and the anatomical and hemodynamic changes could have been established at this point.Nevertheless, the hemodynamic analysis allowed the identification of a a specific brain region : the striatum. It was hypothesized that it acts as a central region for the maintenance of homotopic connectivity, explaining simultaneously the decreased post-surgical homotopic connectivity observed.ConclusionThe highlighted transient postoperative functional homotopy is probably due to multifactorial causes To start entangling these causes, the use of anatomic and hemodynamic imaging data analyses seems crucial to interpret functional connectivity data both immediate and long-term postoperative.Cerebral vasoreactivity and modelling studies provide thereby a very promising tool to better understand the interrelated processes underlying postoperative functional connectivity modifications
Libros sobre el tema "Glioma patients"
Elizabeth, Davies y Hopkins Anthony, eds. Improving care for patients with malignant cerebral glioma. London: Royal College of Physicians, 1997.
Buscar texto completoBinding distribution and cellular uptake of Na2B12H11SH (BSH) in tumor tissue of glioma patients: Investigations for boron neutron capture therapy. Aachen: Shaker, 1997.
Buscar texto completoGuerrero, Douglas. A retrospective analysis investigating the prevalence of epilepsy in patients with gliomas. [Guildford]: [University of Surrey], 1994.
Buscar texto completo(Editor), Elizabeth Davies y Anthony Hopkins (Editor), eds. Improving Care for Patients with Malignant Cerebral Glioma. Royal College of Physicians of London, 1997.
Buscar texto completoSanai, Nader. Low-Grade Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0027.
Texto completoKaley, Thomas J. Oligodendrogliomas. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199937837.003.0128.
Texto completoWeller, Michael, Michael Brada, Tai-Tong Wong y Michael A. Vogelbaum. Astrocytic tumours: diffuse astrocytoma, anaplastic astrocytoma, glioblastoma, and gliomatosis cerebri. Oxford University Press, 2017. http://dx.doi.org/10.1093/med/9780199651870.003.0003.
Texto completoHuntoon, Kristin y J. Bradley Elder. High-Grade Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0001.
Texto completoTaillandier, Luc, Laurent Capelle y Hugues Duffau. New Therapeutic Strategies in Low-grade Gliomas. Nova Science Publishers, 2006.
Buscar texto completoEseonu, Chikezie I., Jordina Rincon-Torroella y Alfredo Quiñones-Hinojosa. Unusual Gliomas. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780190696696.003.0002.
Texto completoCapítulos de libros sobre el tema "Glioma patients"
Fujiwara, S. "Clinical Study Using MRI in Patients Treated with RAFP Therapy". En Treatment of Glioma, 231–40. Tokyo: Springer Japan, 1988. http://dx.doi.org/10.1007/978-4-431-68453-4_15.
Texto completoMori, T. "The Pharmacokinetics of ACNU in Patients with Malignant Brain Tumor". En Treatment of Glioma, 109–16. Tokyo: Springer Japan, 1988. http://dx.doi.org/10.1007/978-4-431-68453-4_4.
Texto completoPuumalainen, Anu-Maaria, Matti Vapalahti y Seppo Ylä-Herttuala. "Gene Therapy for Malignant Glioma Patients". En Advances in Experimental Medicine and Biology, 505–9. Boston, MA: Springer US, 1998. http://dx.doi.org/10.1007/978-1-4615-5357-1_78.
Texto completoFankhauser, Heinz, Giuseppe Stragliotto y Pascal Zbinden. "Borocaptate Sodium (BSH) Pharmacokinetics in Glioma Patients". En Boron Neutron Capture Therapy, 155–62. Boston, MA: Springer US, 1992. http://dx.doi.org/10.1007/978-1-4615-3408-2_17.
Texto completoSmits, Anja y Anette Storstein. "Tumor-Associated Epilepsy in Patients with Glioma". En Tumors of the Central Nervous System, Volume 2, 397–406. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-0618-7_39.
Texto completoWalbert, Tobias y Kristen Chasteen. "Palliative and Supportive Care for Glioma Patients". En Cancer Treatment and Research, 171–84. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-12048-5_11.
Texto completoHam, Timothy y Timothy Rittman. "Neurological Assessment of Patients with Gliomas". En Management of Adult Glioma in Nursing Practice, 37–48. Cham: Springer International Publishing, 2019. http://dx.doi.org/10.1007/978-3-319-76747-5_3.
Texto completoHerold-Mende, Christel y Benito Campos. "Glioma Patients: Role of CD133 Stem Cell Antigen". En Stem Cells and Cancer Stem Cells, Volume 1, 69–76. Dordrecht: Springer Netherlands, 2011. http://dx.doi.org/10.1007/978-94-007-1709-1_8.
Texto completoKaprelyan, A. G., N. M. Mincheva, K. T. Metodiev, D. M. Minchev y D. S. Cholakov. "Immunologic Monitoring in Patients with Glioma Treated Neurosurgically". En Immunology and Its Impact on Infections in Surgery, 196–99. Berlin, Heidelberg: Springer Berlin Heidelberg, 1995. http://dx.doi.org/10.1007/978-3-642-79079-9_28.
Texto completoMaeda, Tatsuhiro, Kazuhiko Saruta, Satoyuki Ito, Hiroki Sawa y Isamu Saito. "Efficiency of Glioma Score in Glioma Patients Using Proliferating Potential with MIB-1 Monoclonal Antibody". En Brain Tumor, 141–48. Tokyo: Springer Japan, 1996. http://dx.doi.org/10.1007/978-4-431-66887-9_15.
Texto completoActas de conferencias sobre el tema "Glioma patients"
Hayashi, Shigeto, Atsushi Sakuma, Takashi Sasayama y Eiji Kohmura. "Measurement of Glioma Viscoelasticity Using a Handheld Palpation Imitation Device". En ASME 2017 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2017. http://dx.doi.org/10.1115/imece2017-70835.
Texto completoBen Abdallah, Meriem, Marie Blonski, Sophie Wantz-Mezieres, Yann Gaudeau, Luc Taillandier y Jean-Marie Moureaux. "Predictive models for diffuse low-grade glioma patients under chemotherapy". En 2016 38th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC). IEEE, 2016. http://dx.doi.org/10.1109/embc.2016.7591692.
Texto completoWijethilake, Navodini, Dulani Meedeniya, Charith Chitraranjan y Indika Perera. "Survival prediction and risk estimation of Glioma patients using mRNA expressions". En 2020 IEEE 20th International Conference on Bioinformatics and Bioengineering (BIBE). IEEE, 2020. http://dx.doi.org/10.1109/bibe50027.2020.00014.
Texto completoPapp, L., S. Rasul, M. Weber, M. Grahovac, T. Beyer, M. Hacker y T. Traub-Weidinger. "Understanding gender pattern differences in MET-PET Glioma patients with radiomics analysis". En NuklearMedizin 2020. © Georg Thieme Verlag KG, 2020. http://dx.doi.org/10.1055/s-0040-1708295.
Texto completoBoisselier, Blandine, Marianne Labussiere, Marta Rossetto, Jaime Gallego Perez Larraya, Yannick Marie, Jean-Yves Delattre y Marc Sanson. "Abstract 5559: Detection of IDH1 mutation in the plasma of glioma patients". En Proceedings: AACR 103rd Annual Meeting 2012‐‐ Mar 31‐Apr 4, 2012; Chicago, IL. American Association for Cancer Research, 2012. http://dx.doi.org/10.1158/1538-7445.am2012-5559.
Texto completoVoigt, Tobias. "Imaging conductivity using electric properties tomography — Initial clinical results in glioma patients". En 2011 XXXth URSI General Assembly and Scientific Symposium. IEEE, 2011. http://dx.doi.org/10.1109/ursigass.2011.6051346.
Texto completoPescatello, Meredith, Nimish Mohile, Jennifer Serventi, Bethann Sayers, Jacqueline Behr, Lauryn Hemminger y Sara Hardy. "Structured Early Advanced Care Planning Outcomes for Patients with High Grade Glioma (S17.006)". En 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000203293.
Texto completoSharma, Puja, Brian Koons y Amrinder S. Nain. "Blebbing Dynamics, Single Cell Force Measurements, and the Influence of Cytochalasin D on Glioblastoma Multiforme Cells Using STEP Fibers". En ASME 2013 2nd Global Congress on NanoEngineering for Medicine and Biology. American Society of Mechanical Engineers, 2013. http://dx.doi.org/10.1115/nemb2013-93105.
Texto completorathore, saima, Spyridon Bakas, Hamed Akbari, MacLean P. Nasrallah, Stephen Bagley y Christos Davatzikos. "Abstract 1392: Machine Learning Radiomic Biomarkers Non-invasively Assess Genetic Characteristics of Glioma Patients". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.sabcs18-1392.
Texto completorathore, saima, Spyridon Bakas, Hamed Akbari, MacLean P. Nasrallah, Stephen Bagley y Christos Davatzikos. "Abstract 1392: Machine Learning Radiomic Biomarkers Non-invasively Assess Genetic Characteristics of Glioma Patients". En Proceedings: AACR Annual Meeting 2019; March 29-April 3, 2019; Atlanta, GA. American Association for Cancer Research, 2019. http://dx.doi.org/10.1158/1538-7445.am2019-1392.
Texto completoInformes sobre el tema "Glioma patients"
Yang, Chao, Tao-junjin Lu, Jie Wang, Qing Zhang, Ze-Fen Wang y Zhi-Qiang Li. Association of systemic immune-inflammation index with grade and prognosis in glioma patients: a systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, abril de 2022. http://dx.doi.org/10.37766/inplasy2022.4.0072.
Texto completoYin, Liangyu, Feifei Chong, Zhenyu Huo, Na Li, Jie Liu y Hongxia Xu. GLIM-defined malnutrition and overall survival in cancer patients: A systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, julio de 2022. http://dx.doi.org/10.37766/inplasy2022.7.0113.
Texto completo